Page 33 - Pharma
Compliance with global standards to make India a pharma manufacturing hub
Building strong infrastructure, ensuring ease of doing business, abolishing price control, encouraging R&D, etc are key factors for the success of Indian pharmaceuticals industry
 "Compliance with global standards to make India a pharma manufacturing hub")
Pfizer to pay $ 784 mn to resolve Medicaid drug rebate claims case
Wyeth, which Pfizer acquired in 2009 & is now its subsidiary, has reached an agreement to resolve Medicaid drug rebate claims for 2001-2006 period for Protonix
 "Pfizer to pay $ 784 mn to resolve Medicaid drug rebate claims case")
Thermo Fisher launches test kits for Zika virus in US
The kits, manufactured by Euroimmun AG, can differentiate between Zika, dengue and chikungunya viruses
Ministry of AYUSH joins hand with WHO to promote traditional medicines
Two side will work towards building capacity, facilitating advocacy and disseminating information on alternative medicines among the member states
 "Ministry of AYUSH joins hand with WHO to promote traditional medicines")
Indo-US vaccine programme to expand
New vaccine development programmes, which include development of affordable vaccines for dengue, respiratory syncytial virus, malaria, etc is expected to be added in the VAP
India can play pivotal role in global biotech industry
Proper standards for good manufacturing and clinical practices are required for India to become a biotechnology hub
 "India can play pivotal role in global biotech industry")
Cipla completes acquisition of InvaGen and Exelan in US
The combined revenue for the two companies for the year-ended 2015 is over $ 230 million
 "Cipla completes acquisition of InvaGen and Exelan in US")
Zydus Cadila receives US FDA nod for anti-bacterial drug doxycycline
The company will commence supplies to the US market from its formulation manufacturing facility at SEZ in Ahmedabad
Glenmark receives tentative US FDA nod for azelaic acid topical gel
The product is a generic version of Bayer Healthcare's Finacea topical gel, which achieved annual sales of approximately $ 128 million in 2015
Big data and analytics can reduce R&D cost in chemical industry
Novel sensors, cheminformatics, and advanced analytics can help bring new products to market faster and cheaper in the chemical industry, says a Lux Research report
 "Big data and analytics can reduce R&D cost in chemical industry")
UK's CMA imposes fine of $ 54 mn on GSK for anti-competitive conduct
Competition and Markets Authority has imposed fines totalling Pound 45 mn (about $ 72 mn) on companies directly involved in the anti-competitive conduct in relation to the supply of paroxetine drug
 "UK's CMA imposes fine of $ 54 mn on GSK for anti-competitive conduct")
Mylan buys Swedish firm Meda for $7.2 bn
The deal will expand Mylan's portfolio of specialty, generic and over-the-counter (OTC) products and provides Mylan with entry into a number of new & attractive emerging markets
 "Mylan buys Swedish firm Meda for $7.2 bn")
Makers Laboratories plans sale of Thane manufacturing unit
The unit, which manufactures bulk drugs and drug intermediates, contributed approximately 14% of the company's total income for 2014-15
Indian Institute of Chemical Biology inks MoU with NRDC to promote entrepreneurship
The partnership expected to contribute to the Start-up India and Make in India missions of Government by way of promoting entrepreneurships, incubation, IPRs, technology transfer, etc
 "Indian Institute of Chemical Biology inks MoU with NRDC to promote entrepreneurship")
Scientific validation must for wider acceptability of homoeopathy
Ministry of AYUSH to develop the four core areas such as education, research, drug development and health care delivery, says stated Shripad Yesso Naik
 "Scientific validation must for wider acceptability of homoeopathy")
Sun Pharma winds down JV with MSD
JV was established in 2011 to develop branded generics for emerging markets
 "Sun Pharma winds down JV with MSD")
European drug regulator approvals Biocon's first generic formulation
The company plans to launch cholesterol lowering drug rosuvastatin, a generic version of AstraZeneca's Crestor, in FY 17
 "European drug regulator approvals Biocon's first generic formulation")
Thermo Fisher buys X-ray diffraction provider Inel
Acquisition to expand Thermo's capabilities in materials science and structural characterisation
Air Liquide's arm Cryo buys pharma logistics firm PDP Couriers
With this acquisition, Cryo combines its know-how in Carboglacetm (or dry ice) and temperature-controlled solutions with a premium logistics service
Global dental product market to exceed $ 12 bn in 2019
The fastest gains will stem from implants, which are increasingly preferred as a durable, long-term alternative to traditional crowns, bridges, and dentures, according to a Freedonia Group report
 "Global dental product market to exceed $ 12 bn in 2019")